Evidence map›Paper›PMID 32329657›Full record

ArticleGut microbes2020

Microbial and metabolic impacts of trehalose and trehalose analogues.

Yiming Zhang, Brian J DeBosch

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification of Primary Metabolites inMethods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Trehalose-Induced Remodelling of the Human Microbiota AffectsFrontiers in cellular and infection microbiology · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yiming ZhangDepartment of Pediatrics, Washington University School of Medicine , St. Louis, MO, USA.ORCID 0000-0002-6020-0237
Brian J DeBoschDepartment of Pediatrics, Washington University School of Medicine , St. Louis, MO, USA.ORCID 0000-0002-9924-7921
Washington University in St. Louis · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
Pediatric Gastroenterology Research Training ProgramT32DK077653 · NIDDK · WASHINGTON UNIVERSITY · PI PHILLIP I TARR · 2007 to 2026
$5.8M
Biological Effects and Mechanistic Actions of the Natural Disaccharide and Dietary Supplement, Trehalose.R21AT010520 · NCCIH · WASHINGTON UNIVERSITY · PI DEBOSCH, BRIAN JESSE · 2019 to 2020
$432k
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolismR56DK115764 · NIDDK · WASHINGTON UNIVERSITY · PI DEBOSCH, BRIAN JESSE · 2018 to 2018
$381k
NCATS NIH HHS UL1 TR002345NCCIH NIH HHS R21 AT010520NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R56 DK115764NIDDK NIH HHS T32 DK077653
6 · The paper itself

Abstract

Trehalose is a disaccharide and fasting-mimetic that has been both canonized and vilified for its putative cardiometabolic and microbial effects. Trehalose analogues are currently under development to extend the key metabolic therapeutic actions of trehalose without adversely affecting host microbial communities. In the current study, we contrast the extent to which trehalose and its degradation-resistant analogue, lactotrehalose (LT), modulate microbial communities and host transcriptomic profiles. We demonstrate that trehalose and LT each exert adaptive metabolic and microbial effects that both overlap and diverge. We postulate that these effects depend both upon compound stability and bioavailability, and on stereospecific signal transduction. In context, the data suggest that trehalose is unlikely to be harmful, and yet it harbors unique effects that are not yet fully replicated by its analogues. These compounds are thus valuable probes to better define trehalose structure-function, and to offer as therapeutic metabolic agents.

Indexed as

AnimalsClostridioides difficileClostridium InfectionsDietary SugarsGastrointestinal MicrobiomeHumansMiceRibotypingStereoisomerismTranscriptomeTrehaloseDietary SugarsTrehaloseClostridioides difficilelactotrehalosemicrobiomeNAFLDtrehalose

Identifiers

PMID32329657
PMCPMC7524367
OpenAlexW3018462653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.